Immunogenicity of Multiple Doses of pDNA Vaccines against SARS-CoV-2

Since its identification in Wuhan, China, in December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has resulted in 46 million cases and more than one million deaths worldwide, as of 30 October 2020. Limited data exist...

Descripción completa

Detalles Bibliográficos
Autores principales: Almansour, Iman, Macadato, Nabela Calamata, Alshammari, Thamer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825551/
https://www.ncbi.nlm.nih.gov/pubmed/33419184
http://dx.doi.org/10.3390/ph14010039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825551/
https://www.ncbi.nlm.nih.gov/pubmed/33419184
http://dx.doi.org/10.3390/ph14010039

Ejemplares similares